Amdocs Ltd has a consensus price target of $103.17, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Citigroup, and Jefferies on February 8, 2024, January 17, 2024, and December 1, 2023. With an average price target of $108 between Barclays, Citigroup, and Jefferies, there's an implied 26.11% upside for Amdocs Ltd from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
02/08/2024 | DOX | Buy Now | Amdocs | $85.64 | 34.28% | Barclays | Tavy Rosner | $105 → $115 | Maintains | Overweight | Get Alert |
01/17/2024 | DOX | Buy Now | Amdocs | $85.64 | 21.44% | Citigroup | Ashwin Shirvaikar | $96 → $104 | Maintains | Buy | Get Alert |
12/01/2023 | DOX | Buy Now | Amdocs | $85.64 | 22.61% | Jefferies | George Notter | → $105 | Initiates | → Buy | Get Alert |
08/03/2023 | DOX | Buy Now | Amdocs | $85.64 | 27.28% | Oppenheimer | Timothy Horan | $99 → $109 | Maintains | Outperform | Get Alert |
05/16/2023 | DOX | Buy Now | Amdocs | $85.64 | 34.28% | Barclays | Tavy Rosner | $100 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
05/11/2023 | DOX | Buy Now | Amdocs | $85.64 | 15.6% | Oppenheimer | Timothy Horan | $99 → $99 | Reiterates | Outperform → Outperform | Get Alert |
02/02/2023 | DOX | Buy Now | Amdocs | $85.64 | 16.77% | Baird | William Power | $85 → $100 | Maintains | Neutral | Get Alert |
02/01/2023 | DOX | Buy Now | Amdocs | $85.64 | 15.6% | Oppenheimer | Timothy Horan | $94 → $99 | Maintains | Outperform | Get Alert |
11/09/2022 | DOX | Buy Now | Amdocs | $85.64 | 12.1% | Citigroup | Ashwin Shirvaikar | $99 → $96 | Maintains | Buy | Get Alert |
08/04/2022 | DOX | Buy Now | Amdocs | $85.64 | 10.93% | Barclays | Tavy Rosner | $89 → $95 | Maintains | Equal-Weight | Get Alert |
08/04/2022 | DOX | Buy Now | Amdocs | $85.64 | 15.6% | Citigroup | Ashwin Shirvaikar | $90 → $99 | Maintains | Buy | Get Alert |
05/12/2022 | DOX | Buy Now | Amdocs | $85.64 | 5.09% | Citigroup | Ashwin Shirvaikar | $93 → $90 | Maintains | Buy | Get Alert |
12/14/2021 | DOX | Buy Now | Amdocs | $85.64 | 0.42% | JP Morgan | Jackson Ader | — | Downgrade | Overweight → Neutral | Get Alert |
08/05/2021 | DOX | Buy Now | Amdocs | $85.64 | 15.6% | Oppenheimer | Timothy Horan | — | Maintains | Outperform | Get Alert |
The latest price target for Amdocs (NASDAQ: DOX) was reported by Barclays on February 8, 2024. The analyst firm set a price target for $115.00 expecting DOX to rise to within 12 months (a possible 34.28% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Amdocs (NASDAQ: DOX) was provided by Barclays, and Amdocs maintained their overweight rating.
The last upgrade for Amdocs Ltd happened on May 16, 2023 when Barclays raised their price target to $115. Barclays previously had an equal-weight for Amdocs Ltd.
The last downgrade for Amdocs Ltd happened on December 14, 2021 when JP Morgan changed their price target from $91 to $86 for Amdocs Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amdocs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amdocs was filed on February 8, 2024 so you should expect the next rating to be made available sometime around February 8, 2025.
While ratings are subjective and will change, the latest Amdocs (DOX) rating was a maintained with a price target of $105.00 to $115.00. The current price Amdocs (DOX) is trading at is $85.64, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.